Female (93); Male (136); Unknown (2)

0 to 4 years (61); 5 to 9 years (28); 10 to 14 years (54); 15 to 19 years (41); 20 to 24 years (17); 25 to 29 years (4); 30 to 34 years (3); 34 to 39 years (1); Greater than 39 years (2); Not Reported (26)

American Indian or Alaska Native (2); Asian (37); Black or African American (12); Native Hawaiian or other Pacific Islander (2); White (80); Not Reported (74); Unknown (24)

Hispanic or Latino (71); Not Hispanic or Latino (115); Not Reported (21); Unknown (24)

Acinar cell carcinoma (1); Acute megakaryoblastic leukemia (1); Acute myeloid leukemia with myelodysplasia-related changes (1); Acute myeloid leukemia, NOS (10); Adrenal cortical carcinoma (4); Aggressive fibromatosis (2); Alveolar rhabdomyosarcoma (7); Astrocytoma, NOS (2); B lymphoblastic leukemia/lymphoma with hypodiploidy (Hypodiploid ALL) (1); B lymphoblastic leukemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1) (1); B lymphoblastic leukemia/lymphoma with t(9;22)(q34;q11.2); BCR-ABL1 (1); B lymphoblastic leukemia/lymphoma, NOS (15); Chondroblastic osteosarcoma (4); Chronic myelogenous leukemia, BCR/ABL positive (1); Clear cell adenocarcinoma, NOS (1); Embryonal rhabdomyosarcoma, NOS (7); Embryonal sarcoma (1); Ependymoma, anaplastic (3); Ependymoma, NOS (2); Epithelioid hemangioendothelioma, NOS (1); Ewing sarcoma (18); Ganglioneuroblastoma (3); Glioma, malignant (1); Gliosarcoma (1); Hepatoblastoma, NOS (18); Hepatocellular carcinoma, fibrolamellar (2); Hepatocellular carcinoma, NOS (2); Infantile fibrosarcoma (3); Juvenile myelomonocytic leukemia, NOS (2); Lymphoepithelial carcinoma (1); Malignant melanoma, NOS (3); Malignant peripheral nerve sheath tumor, NOS (5); Medulloblastoma, NOS (2); Mixed phenotype acute leukemia, B/myeloid, NOS (2); Mixed phenotype acute leukemia, T/myeloid, NOS (1); Myofibromatosis (1); Myxoid liposarcoma (1); Nephroblastoma, NOS (5); Neuroblastoma, NOS (16); Osteosarcoma, NOS (47); Paraganglioma, malignant (1); Parosteal osteosarcoma (1); Periosteal osteosarcoma (3); Pilocytic astrocytoma (1); Rhabdomyosarcoma, NOS (9); Sarcoma, NOS (6); Spindle cell rhabdomyosarcoma (3); Squamous cell carcinoma, large cell, nonkeratinizing, NOS (2); Synovial sarcoma, NOS (6); Teratoma, malignant, NOS (1); Undifferentiated sarcoma (2); Yolk sac tumor, NOS (2)

Abdomen, NOS (4); Adrenal gland, NOS (10); Bone marrow (31); Bones of skull and face and associated joints (3); Brain, NOS (9); Cerebellum, NOS (1); Connective, subcutaneous and other soft tissues of abdomen (5); Connective, subcutaneous and other soft tissues of head, face, and neck (6); Connective, subcutaneous and other soft tissues of lower limb and hip (15); Connective, subcutaneous and other soft tissues of pelvis (5); Connective, subcutaneous and other soft tissues of thorax (5); Connective, subcutaneous and other soft tissues of trunk, NOS (5); Connective, subcutaneous and other soft tissues of upper limb and shoulder (4); Exocervix (1); Head, face or neck, NOS (2); Kidney, NOS (5); Liver (25); Long bones of lower limb and associated joints (41); Long bones of upper limb, scapula and associated joints (10); Lower limb, NOS (1); Lung, NOS (2); Lymph nodes of axilla or arm (1); Maxillary sinus (3); Mediastinum, NOS (1); Nasal cavity (1); Nasopharynx, NOS (5); Orbit, NOS (2); Ovary (2); Parotid gland (1); Pelvic bones, sacrum, coccyx and associated joints (6); Posterior mediastinum (1); Retroperitoneum (1); Skin of lower limb and hip (2); Spinal cord (1); Testis, NOS (1); Thymus (1); Upper limb, NOS (1); Unknown (17)

RNA Sequencing (291); Whole Genome Sequencing (466)

Yes (187); No (366); Not Reported (1)